Analyses of available pretreatment tumor biopsy samples reported that patients displaying higher baseline levels of LAG-3 expression by IHC tended to show improved response (Extended Data Fig. 6d and Supplementary Fig. 6). The gene discussed is LAG3; the disease is neoplasm.